Matrix Metalloproteinases in Subjects With Type 2 Diabetes Mellitus: Pattern of MMP-2 and MMP-9 Profile in Diabetes Mellitus Type-2 Patients

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.

  2008cited by this paper
• UKPDS—modelling of cardiovascular risk assessment and lifetime simulation of outcomes

  2008cited by this paper
• An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.

  2006cited by this paper
• Reduced Expression of Vascular Endothelial Growth Factor Paralleled With the Increased Angiostatin Expression Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in Human Type 2 Diabetic Arterial Vasculature

  2006cited by this paper
• Matrix Metalloproteinases and Diabetic Vascular Complications

  2005cited by this paper
• Establishment of a diabetic mouse model with progressive diabetic nephropathy.

  2005cited by this paper
• Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling.

  2004cited by this paper
• Isolation of MMP-2 from MMP-2/TIMP-2 complex: characterization of the complex and the free enzyme in pulmonary vascular smooth muscle plasma membrane.

  2004cited by this paper
• [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].

  2003cited by this paper
• Métalloprotéases matricielles et athérosclérose. Perspectives thérapeutiques

  2003cited by this paper
• Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.

  2002cited by this paper
• Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes.

  2002cited by this paper
• Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

  2002cited by this paper
• Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.

  2001cited by this paper
• Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic Stroke

  2001cited by this paper
• Plaque disruption and thrombosis. Potential role of inflammation and infection.

  1999cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998cited by this paper
• Matrix Metalloproteinases in Cerebrovascular Disease

  1998cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Diabetes as an atherogenic factor.

  1984cited by this paper
• An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

  1981cited by this paper
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinase: Regulation and Dysregulation in the failing Heart Matrix M

  year unknowncited by this paper

• Matrix Metalloproteinase 2 and Interleukin 29 as Novel Biochemical Markers for Neurovascular Complications among Type 2 Diabetic Elderly Patients

  2024cites this paper
• The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation

  2016cites this paper